Clinton Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-127,179
Closed -$2.82M 402
2018
Q1
$2.82M Sell
127,179
-80,340
-39% -$2.22M 0.3% 110
2017
Q4
$6.31M Buy
207,519
+15,870
+8% +$422K 0.55% 52
2017
Q3
$4.64M Buy
+191,649
New +$5.1M 0.51% 63
2017
Q2
Sell
-37,741
Closed -$818K 654
2017
Q1
$818K Buy
37,741
+23,397
+163% +$476K 0.05% 467
2016
Q4
$214K Sell
14,344
-25,960
-64% -$375K 0.01% 761
2016
Q3
$515K Buy
+40,304
New +$436K 0.02% 667

Other funds holding EXEL

Clinton Group's EXEL Position: Q2 2018 in Review

Clinton Group sold out of Exelixis (EXEL) in Q2 2018, closing a stake of 127,179 shares — an estimated $2.82M sold.

Clinton Group first reported a position in EXEL in Q3 2016 and held it in 6 quarters. The position peaked at $6.31M in Q4 2017. 303 funds tracked by Wall St. Rank hold EXEL as of Q2 2018.

  • Clinton Group reported no remaining Exelixis position as of Q2 2018 after selling out during the quarter.
  • Clinton Group sold 127,179 Exelixis shares in Q2 2018, an estimated $2.82M.
  • Clinton Group first reported a position in Exelixis in Q3 2016 and held it in 6 quarters.
  • Clinton Group's Exelixis position peaked at $6.31M in Q4 2017.
  • 303 funds tracked by Wall St. Rank held Exelixis as of Q2 2018.

Based on Clinton Group's 13F filing for Q2 2018, filed 6 Jul 2018.